Search

Your search keyword '"Travassos, Mark A."' showing total 30 results

Search Constraints

Start Over You searched for: Author "Travassos, Mark A." Remove constraint Author: "Travassos, Mark A." Topic malaria Remove constraint Topic: malaria
30 results on '"Travassos, Mark A."'

Search Results

1. Gene expression analyses reveal differences in children's response to malaria according to their age.

2. Natural immunity to malaria preferentially targets the endothelial protein C receptor-binding regions of PfEMP1s.

Catalog

Books, media, physical & digital resources

3. Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles.

4. Protein Microarrays as a Tool to Analyze Antibody Responses to Variant Surface Antigens Expressed on the Surface of Plasmodium falciparum-Infected Erythrocytes.

5. A Decline and Age Shift in Malaria Incidence in Rural Mali following Implementation of Seasonal Malaria Chemoprevention and Indoor Residual Spraying.

6. Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure.

7. Spatio-Temporal Dynamics of Asymptomatic Malaria: Bridging the Gap Between Annual Malaria Resurgences in a Sahelian Environment.

8. Mother-Newborn Pairs in Malawi Have Similar Antibody Repertoires to Diverse Malaria Antigens.

9. Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali.

11. Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome

12. Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination

13. Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag

15. Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets

16. Mother-Newborn Pairs in Malawi Have Similar Antibody Repertoires to Diverse Malaria Antigens

17. Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge.

18. Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential

19. Seroreactivity to Plasmodium falciparum Erythrocyte Membrane Protein 1 Intracellular Domain in Malaria-Exposed Children and Adults

20. Shifts in the clinical epidemiology of severe malaria after scaling up control strategies in Mali.

21. Epitope-Specific Antibody Responses to a Plasmodium falciparum Subunit Vaccine Target in a Malaria-Endemic Population.

22. Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults.

24. 272 Differential expression of two Plasmodium falciparum variant surface antigen families in Malian children with cerebral malaria compared to mild malaria.

25. A new method for sequencing the hypervariable Plasmodium falciparum gene var2csa from clinical samples.

26. New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali.

27. Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children.

28. Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali.

29. Severe Malaria Treatment in the United States at the Precipice.

30. Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.